Location History:
- Bronx, NY (US) (1978)
- New York, NY (US) (2014)
- Evanston, IL (US) (2017 - 2018)
Company Filing History:
2 out of 822 
1 out of 4,554 
2 out of 832,880 Years Active: 1978-2018
Title: Innovations and Contributions of John Hartung
Introduction
John Hartung is a notable inventor based in Evanston, IL, with a significant portfolio of five patents. His work primarily focuses on advancements in the fields of virology and catalysis, showcasing his commitment to innovation and scientific progress.
Latest Patents
Among his latest patents, Hartung has developed anti-viral compounds that are effective in inhibiting the Hepatitis C virus (HCV) polymerase. This invention not only includes the compounds themselves but also the processes for making them, compositions that comprise these compounds, and methods for using them to treat HCV infections. Another significant patent involves selective olefin metathesis with cyclometalated ruthenium complexes. This invention pertains to C—H activated ruthenium olefin metathesis catalyst compounds that are stereogenic at the ruthenium center. It details their preparation and application in various metathesis reactions, which have utility in catalysis, organic synthesis, polymer chemistry, and the production of industrial and fine chemicals.
Career Highlights
Throughout his career, Hartung has made substantial contributions to the scientific community. His innovative work has led to advancements that are not only theoretical but also practical, impacting various industries.
Collaborations
Hartung has collaborated with esteemed colleagues such as Hui-Ju J Chen and David A DeGoey, further enhancing the scope and impact of his inventions.
Conclusion
John Hartung's contributions to the fields of virology and catalysis through his patents reflect his dedication to innovation and scientific advancement. His work continues to influence various sectors, demonstrating the importance of research and development in addressing complex challenges.